Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $104,000 - $61.5 Million
-800,000 Reduced 38.46%
1,280,000 $91 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $380 Million - $443 Million
-7,087,454 Reduced 77.31%
2,080,000 $130 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $19.5 Million - $22.8 Million
-329,332 Reduced 3.47%
9,167,454 $542 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $77.7 Million - $84.6 Million
-1,255,224 Reduced 11.67%
9,496,786 $635 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $38.8 Million - $43.7 Million
654,514 Added 6.48%
10,752,010 $679 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $49.8 Million - $56.4 Million
-862,655 Reduced 7.87%
10,097,496 $626 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $4,536 - $5,027
-79 Reduced -0.0%
10,960,151 $661 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $129 Million - $150 Million
-2,347,252 Reduced 17.64%
10,960,230 $644 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $27.9 Million - $40.6 Million
601,947 Added 4.74%
13,307,482 $742 Million
Q4 2019

Feb 18, 2020

BUY
$49.21 - $64.19 $14.9 Million - $19.5 Million
303,014 Added 2.44%
12,705,535 $816 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $25.6 Million - $30.4 Million
-599,630 Reduced 4.61%
12,402,521 $629 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $27.6 Million - $30.5 Million
-618,349 Reduced 4.54%
13,002,151 $590 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $76.7 Million - $91.5 Million
1,700,000 Added 14.26%
13,620,500 $650 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $336 Million - $436 Million
-6,895,354 Reduced 36.65%
11,920,500 $620 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $353 Million - $398 Million
-6,394,203 Reduced 25.36%
18,815,854 $1.17 Billion
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $202 Million - $252 Million
-3,999,751 Reduced 13.69%
25,210,057 $1.4 Billion
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $9.96 Million - $11.5 Million
-166,300 Reduced 0.57%
29,209,808 $1.85 Billion
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $135 Million - $147 Million
-2,250,002 Reduced 7.11%
29,376,108 $1.8 Billion
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $1.75 Billion - $2.02 Billion
31,626,110
31,626,110 $2.02 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.